VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.02 Cr | ₹-1.08 Cr | ₹-0.57 Cr | ₹-9.48 Cr | ₹-162 Cr |
What is the latest Cash Flow from Financing Activities ratio of VENUS REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.02 Cr |
| Mar2024 | ₹-1.08 Cr |
| Mar2023 | ₹-0.57 Cr |
| Mar2022 | ₹-9.48 Cr |
| Mar2021 | ₹-162 Cr |
How is Cash Flow from Financing Activities of VENUS REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.02 Cr | Negative | |
| Mar2024 | ₹-1.08 Cr | Negative | |
| Mar2023 | ₹-0.57 Cr | Negative | |
| Mar2022 | ₹-9.48 Cr | Negative | |
| Mar2021 | ₹-162 Cr | - | |
Compare Cash Flow from Financing Activities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,396.7 Cr | 4.9% | 16.6% | 248.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 4.9% |
16.6% |
248.3% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses